121 related articles for article (PubMed ID: 28881730)
1. Suppression of microRNA-205-5p in human mesenchymal stem cells improves their therapeutic potential in treating diabetic foot disease.
Zhu L; Wang G; Fischbach S; Xiao X
Oncotarget; 2017 Aug; 8(32):52294-52303. PubMed ID: 28881730
[TBL] [Abstract][Full Text] [Related]
2. Improved therapeutic effects on diabetic foot by human mesenchymal stem cells expressing MALAT1 as a sponge for microRNA-205-5p.
Zhu L; Zhong Q; Yang T; Xiao X
Aging (Albany NY); 2019 Dec; 11(24):12236-12245. PubMed ID: 31866580
[TBL] [Abstract][Full Text] [Related]
3. Expression of antisense of microRNA-26a-5p in mesenchymal stem cells increases their therapeutic effects against cirrhosis.
Chen L; Zeng W; Yang B; Cui X; Feng C; Wang L; Wang H; Zhou X; Li P; Lv F; Li T
Am J Transl Res; 2017; 9(3):1500-1508. PubMed ID: 28386375
[TBL] [Abstract][Full Text] [Related]
4. miR-486-5p induces replicative senescence of human adipose tissue-derived mesenchymal stem cells and its expression is controlled by high glucose.
Kim YJ; Hwang SH; Lee SY; Shin KK; Cho HH; Bae YC; Jung JS
Stem Cells Dev; 2012 Jul; 21(10):1749-60. PubMed ID: 21988232
[TBL] [Abstract][Full Text] [Related]
5. miR-342-5p Is a Notch Downstream Molecule and Regulates Multiple Angiogenic Pathways Including Notch, Vascular Endothelial Growth Factor and Transforming Growth Factor β Signaling.
Yan XC; Cao J; Liang L; Wang L; Gao F; Yang ZY; Duan JL; Chang TF; Deng SM; Liu Y; Dou GR; Zhang J; Zheng QJ; Zhang P; Han H
J Am Heart Assoc; 2016 Feb; 5(2):. PubMed ID: 26857067
[TBL] [Abstract][Full Text] [Related]
6. Peritoneal fluid modifies the microRNA expression profile in endometrial and endometriotic cells from women with endometriosis.
Braza-Boïls A; Salloum-Asfar S; Marí-Alexandre J; Arroyo AB; González-Conejero R; Barceló-Molina M; García-Oms J; Vicente V; Estellés A; Gilabert-Estellés J; Martínez C
Hum Reprod; 2015 Oct; 30(10):2292-302. PubMed ID: 26307093
[TBL] [Abstract][Full Text] [Related]
7. Improvement of therapeutic effects of mesenchymal stem cells in myocardial infarction through genetic suppression of microRNA-142.
Yang LX; Wei CL; Guo ML; Zhang Y; Bai F; Ma SG
Oncotarget; 2017 Oct; 8(49):85549-85558. PubMed ID: 29156740
[TBL] [Abstract][Full Text] [Related]
8. The role of bone marrow mesenchymal stromal cell derivatives in skin wound healing in diabetic mice.
de Mayo T; Conget P; Becerra-Bayona S; Sossa CL; Galvis V; Arango-Rodríguez ML
PLoS One; 2017; 12(6):e0177533. PubMed ID: 28594903
[TBL] [Abstract][Full Text] [Related]
9. [Effect of different transplantations with bone-marrow derived mesenchymal stem cells on diabetic foot ulcers in rats].
Wan J; Cai Q; Liu Y
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2013 Apr; 38(4):347-55. PubMed ID: 23645234
[TBL] [Abstract][Full Text] [Related]
10. Modulation of mesenchymal stem cells with miR-375 to improve their therapeutic outcome during scar formation.
Sheng W; Feng Z; Song Q; Niu H; Miao G
Am J Transl Res; 2016; 8(5):2079-87. PubMed ID: 27347316
[TBL] [Abstract][Full Text] [Related]
11. VEGF gene transfected umbilical cord mesenchymal stem cells transplantation improve the lower limb vascular lesions of diabetic rats.
Li X; Gan K; Song G; Wang C
J Diabetes Complications; 2015; 29(7):872-81. PubMed ID: 26077346
[TBL] [Abstract][Full Text] [Related]
12. Neurotrophin-3 accelerates wound healing in diabetic mice by promoting a paracrine response in mesenchymal stem cells.
Shen L; Zeng W; Wu YX; Hou CL; Chen W; Yang MC; Li L; Zhang YF; Zhu CH
Cell Transplant; 2013; 22(6):1011-21. PubMed ID: 23043768
[TBL] [Abstract][Full Text] [Related]
13. MicroRNA-590-5p Stabilizes Runx2 by Targeting Smad7 During Osteoblast Differentiation.
Vishal M; Vimalraj S; Ajeetha R; Gokulnath M; Keerthana R; He Z; Partridge NC; Selvamurugan N
J Cell Physiol; 2017 Feb; 232(2):371-380. PubMed ID: 27192628
[TBL] [Abstract][Full Text] [Related]
14. Human skin-derived mesenchymal stem cells as a source of VEGF and nitric oxide.
Salvolini E; Lucarini G; Zizzi A; Orciani M; Di Benedetto G; Di Primio R
Arch Dermatol Res; 2010 Jul; 302(5):367-74. PubMed ID: 20035428
[TBL] [Abstract][Full Text] [Related]
15. microRNA-378 promotes mesenchymal stem cell survival and vascularization under hypoxic-ischemic conditions in vitro.
Xing Y; Hou J; Guo T; Zheng S; Zhou C; Huang H; Chen Y; Sun K; Zhong T; Wang J; Li H; Wang T
Stem Cell Res Ther; 2014 Nov; 5(6):130. PubMed ID: 25418617
[TBL] [Abstract][Full Text] [Related]
16. Effect of brain-derived neurotrophic factor on mesenchymal stem cell-seeded electrospinning biomaterial for treating ischemic diabetic ulcers via milieu-dependent differentiation mechanism.
He S; Shen L; Wu Y; Li L; Chen W; Hou C; Yang M; Zeng W; Zhu C
Tissue Eng Part A; 2015 Mar; 21(5-6):928-38. PubMed ID: 25316594
[TBL] [Abstract][Full Text] [Related]
17. MiR-335-5p promotes chondrogenesis in mouse mesenchymal stem cells and is regulated through two positive feedback loops.
Lin X; Wu L; Zhang Z; Yang R; Guan Q; Hou X; Wu Q
J Bone Miner Res; 2014 Jul; 29(7):1575-85. PubMed ID: 24347469
[TBL] [Abstract][Full Text] [Related]
18. miR-204-5p promotes the adipogenic differentiation of human adipose-derived mesenchymal stem cells by modulating DVL3 expression and suppressing Wnt/β-catenin signaling.
He H; Chen K; Wang F; Zhao L; Wan X; Wang L; Mo Z
Int J Mol Med; 2015 Jun; 35(6):1587-95. PubMed ID: 25847080
[TBL] [Abstract][Full Text] [Related]
19. Metformin inhibits development of diabetic retinopathy through microRNA-497a-5p.
Zhang Y; Chen F; Wang L
Am J Transl Res; 2017; 9(12):5558-5566. PubMed ID: 29312507
[TBL] [Abstract][Full Text] [Related]
20. The toll-like receptor 3 ligand, poly(I:C), improves immunosuppressive function and therapeutic effect of mesenchymal stem cells on sepsis via inhibiting MiR-143.
Zhao X; Liu D; Gong W; Zhao G; Liu L; Yang L; Hou Y
Stem Cells; 2014 Feb; 32(2):521-33. PubMed ID: 24105952
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
